HealthNotableReported
5.0
Ireland HSE delays decision on Mounjaro reimbursement over multibillion-euro cost
The JournalLO·IE·about 16 hours ago
A new clinical trial will test GLP-1 weight-loss drugs for their effect on substance use disorders, following promising early results. The study also examines impacts on criminal justice involvement, employment, and housing stability. This expands the potential therapeutic scope of GLP-1s beyond metabolic conditions, though efficacy remains unproven.
Entities